Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma. Tune in as we chat with Dr. Yasmin Karimi from the University of Michigan about the latest breakthroughs in treatment, including combination therapies, CAR T-cell therapy and bispecific antibodies. Discover how these innovations are offering new hope and pathways to cures for patients.
Lenacapavir Named 2024 Breakthrough of the Year by Science Magazine Foster City, Calif., December 19, 2024 – Gilead Sciences, Inc. today announced the company completed…
Michael R. Gieske, MD, of the St. Elizabeth Cancer Center, discusses the Rural Appalachian Lung Cancer Screening Initiative at IASLC 2024 World Conference on Lung…
Recorded at the 66th American Society of Hematology Annual Meeting and Exposition, Yuan Yao, MD, MS, discusses the ASH abstract (No.397) titled,
AbstractWe present a case of a 76-year-old man with de novo right heart failure. Echocardiography initially detected a mass near to the posterior area of…
Patients with polycythemia vera who switched from hydroxyurea to ruxolitinib showed improved hematocrit and white blood cell count control, according to an ASH 2024 presentation.
Baxter International has resumed all peritoneal dialysis solutions manufacturing lines at the North Cove, North Carolina, facility that was damaged during Hurricane Helene.
Offering the most up-to-date, comprehensive lens on the global burden of cardiovascular diseases (CVDs) and risk factors, JACC, the Institute for Health Metrics and Evaluation,…
Tis the season for revenge! For President Joe Biden is spending the remaining weeks of his presidency settling scores.
Dr. Jim Brugarolas joins the podcast to discuss his talk from IKCS 2024 and the broad topic of resistance to HIF inhibitors.
The American College of Cardiology is seeking its next Editor-in-Chief for JACC: Basic to Translational Science (JACC: BTS), an exciting leadership opportunity for a visionary…
